[1]
|
Kochar, B., Akshintala, V.S., Afghani, E., et al. (2015) Incidence, Severity, and Mortality of Post-ERCP Pancreatitis: A Systematic Review by Using Randomized, Controlled Trials. Gastrointestinal Endoscopy, 81, 143-149.e9.
https://doi.org/10.1016/j.gie.2014.06.045
|
[2]
|
Wang, A.Y., Strand, D.S. and Shami, V.M. (2016) Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Medications and Techniques. Clinical Gastroenterology and Hepatology, 14, 1521-1532.e3.
https://doi.org/10.1016/j.cgh.2016.05.026
|
[3]
|
Cotton, P.B., Garrow, D.A., Gallagher, J. and Romagnuolo, J. (2009) Risk Factors for Complications after ERCP: A Multivariate Analysis of 11,497 Procedures over 12 Years. Gastrointestinal Endoscopy, 70, 80-88.
https://doi.org/10.1016/j.gie.2008.10.039
|
[4]
|
Ethridge, R.T., Chung, D.H., Slogoff, M., Ehlers, R.A., Hellmich, M.R., Rajaraman, S., et al. (2002) Cyclooxygenase-2 Gene Disruption Attenuatesthe Severity of Acute Pancreatitis and Pancreatitis-Associated Lunginjury. Gastroenterology, 123, 1311-1322. https://doi.org/10.1053/gast.2002.35951
|
[5]
|
ASGE Standards of Practice Committee, Chandrasekhara, V., Khashab, M.A., et al. (2017) Adverse Events Associated with ERCP. Gastrointestinal Endoscopy, 85, 32-47. https://doi.org/10.1016/j.gie.2016.06.051
|
[6]
|
Dumonceau, J.M., Kapral, C., Aabakken, L., et al. (2020) ERCP-Related Adverse Events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 52, 127-149. https://doi.org/10.1055/a-1075-4080
|
[7]
|
Serrano, J.P.R., de Moura, D.T.H., Bernardo, W.M., et al. (2019) Nonsteroidal Anti-Inflammatory Drugs versus Placebo for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-Analysis. Endoscopy International Open, 7, E477-E486. https://doi.org/10.1055/a-0862-0215
|
[8]
|
Yang, J., Wang, W., Liu, C., Zhao, Y., Ren, M. and He, S. (2020) Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: A Network Meta-Analysis. Journal of Clinical Gastroenterology, 54, 305-313. https://doi.org/10.1097/MCG.0000000000001322
|
[9]
|
Radadiya, D., Brahmbhatt, B., Reddy, C. and Devani, K. (2021) Efficacy of Combining Aggressive Hydration with Rectal Indomethacin in Preventing Post-ERCP Pancreatitis: A Systematic Review and Network Meta-Analysis. Journal of Clinical Gastroenterology. https://doi.org/10.1097/MCG.0000000000001523
|
[10]
|
Hutton, B., Salanti, G., Caldwell, D.M., et al. (2015) The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-Analyses of Health Care Interventions: Checklist and Explanations. Annals of Internal Medicine, 162, 777-784. https://doi.org/10.7326/M14-2385
|
[11]
|
Sperna Weiland, C.J., Smeets, X.J.N.M., Kievit, W., et al. (2021) Aggressive Fluid Hydration plus Non-Steroidal Anti-Inflammatory Drugs versus Non-Steroidal Anti-Inflammatory Drugs Alone for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis (FLUYT): A Multicentre, Open-Label, Randomised, Controlled Trial. The Lancet Gastroenterology and Hepatology, 6, 350-358. https://doi.org/10.1016/S2468-1253(21)00057-1
|
[12]
|
Hosseini, M., Shalchiantabrizi, P., Yektaroudy, K., Dadgarmoghaddam, M. and Salari, M. (2016) Prophylactic Effect of Rectal Indomethacin Administration, with and without Intravenous Hydration, on Development of Endoscopic Retrograde Cholangiopancreatography Pancreatitis Episodes: A Randomized Clinical Trial. Archives of Iranian Medicine, 19, 538-543.
|
[13]
|
Lai, J.H., Hung, C.Y., Chu, C.H., et al. (2019) A Randomized Trial Comparing the Efficacy of Single-Dose and Double-Dose Administration of Rectal Indomethacin in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Medicine (Baltimore), 98, e15742. https://doi.org/10.1097/MD.0000000000015742
|
[14]
|
Andrade-Dávila, V.F., Chávez-Tostado, M., Dávalos-Cobián, C., et al. (2015) Rectal Indomethacin versus Placebo to Reduce the Incidence of Pancreatitis after Endoscopic Retrograde Cholangiopancreatography: Results of a Controlled Clinical Trial. BMC Gastroenterology, 15, Article No. 85. https://doi.org/10.1186/s12876-015-0314-2
|
[15]
|
Döbrönte, Z., Szepes, Z., Izbéki, F., et al. (2014) Is Rectal Indomethacin Effective in Preventing of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis? World Journal of Gastroenterology, 20, 10151-10157.
https://doi.org/10.3748/wjg.v20.i29.10151
|
[16]
|
Uçar, R., Biyik, M., Uçar, E., et al. (2016) Rectal or Intramuscular Diclofenac Reduces the Incidence of Pancreatitis after Endoscopic Retrograde Cholangiopancreatography. Turkish Journal of Medical Sciences, 46, 1059-1063.
https://doi.org/10.3906/sag-1502-104
|
[17]
|
Kamal, A., Akshintala, V.S., Talukdar, R., et al. (2019) A Randomized Trial of Topical Epinephrine and Rectal Indomethacin for Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients. American Journal of Gastroenterology, 114, 339-347. https://doi.org/10.14309/ajg.0000000000000049
|
[18]
|
Wang, Y., Xu, B., Zhang, W., et al. (2020) Prophylactic Effect of Rectal Indomethacin plus Nitroglycerin Administration for Preventing Pancreatitis after Endoscopic Retrograde Cholangiopancreatography in Female Patients. Annals of Palliative Medicine, 9, 4029-4037. https://doi.org/10.21037/apm-20-1963
|
[19]
|
Romano-Munive, A.F., García-Correa, J.J., García-Contreras, L.F., et al. (2021) Can Topical Epinephrine Application to the Papilla Prevent Pancreatitis after Endoscopic Retrograde Cholangiopancreatography? Results from a Double Blind, Multicentre, Placebo Controled, Randomised Clinical Trial. BMJ Open Gastroenterology, 8, e000562.
https://doi.org/10.1136/bmjgast-2020-000562
|
[20]
|
Elmunzer, B.J., Scheiman, J.M., Lehman, G.A., et al. (2012) A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis. The New England Journal of Medicine, 366, 1414-1422.
https://doi.org/10.1056/NEJMoa1111103
|
[21]
|
Norouzi, A., Ghasem Poori, E., Kaabe, S., et al. (2021) Effect of Adding Intravenous Somatostatin to Rectal Indomethacin on Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis in High-Risk Patients: A Double-Blind Randomized Placebo-Controlled Clinical Trial. Journal of Clinical Gastroenterology, 10, 1097.
https://doi.org/10.1097/MCG.0000000000001563
|
[22]
|
Fogel, E.L., Lehman, G.A., Tarnasky, P., et al. (2020) Rectal Indometacin Dose Escalation for Prevention of Pancreatitis after Endoscopic Retrograde Cholangiopancreatography in High-Risk Patients: A Double-Blind, Randomised Controlled Trial. The Lancet Gastroenterology and Hepatology, 5, 132-141.
https://doi.org/10.1016/S2468-1253(19)30337-1
|
[23]
|
Hatami, B., Kashfi, S.M.H., Abbasinazari, M., et al. (2018) Epinephrine in the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Preliminary Study. Case Reports in Gastroenterology, 12, 125-136.
https://doi.org/10.1159/000479494
|
[24]
|
Sotoudehmanesh, R., Khatibian, M., Kolahdoozan, S., Ainechi, S., Malboosbaf, R. and Nouraie, M. (2007) Indomethacin May Reduce the Incidence and Severity of Acute Pancreatitis after ERCP. American Journal of Gastroenterology, 102, 978-983. https://doi.org/10.1111/j.1572-0241.2007.01165.x
|
[25]
|
Katsinelos, P., Fasoulas, K., Paroutoglou, G., et al. (2012) Combination of Diclofenac plus Somatostatin in the Prevention of Post-ERCP Pancreatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Endoscopy, 44, 53-59.
https://doi.org/10.1055/s-0031-1291440
|
[26]
|
Khoshbaten, M., Khorram, H., Madad, L., EhsaniArdakani, M.J., Farzin, H. and Zali, M.R. (2008) Role of Diclofenac in Reducing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Journal of Gastroenterology and Hepatology, 23, e11-e16. https://doi.org/10.1111/j.1440-1746.2007.05096.x
|
[27]
|
MontañoLoza, A., Rodríguez Lomelí, X., García Correa, J.E., et al. (2007) Efecto de la administración de indometacina rectal sobre los nivelesséricos de amilasaposteriores a colangiopancreatografíaretrógradaendoscópica y suimpactoen la aparición de episodios de pancreatitis secundaria [Effect of the Administration of Rectal Indomethacin on Amylase Serum Levels after Endoscopic Retrograde Cholangiopancreatography, and Its Impact on the Development of Secondary Pancreatitis Episodes]. Revista Espanola de Enfermedades Digestivas, 99, 330-336.
https://doi.org/10.4321/S1130-01082007000600005
|
[28]
|
Lua, G.W., Muthukaruppan, R. and Menon, J. (2015) Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis? Digestive Diseases and Sciences, 60, 3118-3123.
https://doi.org/10.1007/s10620-015-3609-9
|
[29]
|
Luo, H., Zhao, L., Leung, J., et al. (2016) Routine Pre-Procedural Rectal Indometacin versus Selective Post-Procedural Rectal Indometacin to Prevent Pancreatitis in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Multicentre, Single-Blinded, Randomised Controlled Trial. The Lancet, 387, 2293-2301.
https://doi.org/10.1016/S0140-6736(16)30310-5
|
[30]
|
Luo, H., Wang, X., Zhang, R., et al. (2019) Rectal Indomethacin and Spraying of Duodenal Papilla with Epinephrine Increases Risk of Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography. Clinical Gastroenterology and Hepatology, 17, 1597-1606.e5. https://doi.org/10.1016/j.cgh.2018.10.043
|
[31]
|
Mok, S.R.S., Ho, H.C., Shah, P., Patel, M., Gaughan, J.P. and Elfant, A.B. (2017) Lactated Ringer’s Solution in Combination with Rectal Indomethacin for Prevention of Post-ERCP Pancreatitis and Readmission: A Prospective Randomized, Double-Blinded, Placebo-Controlled Trial. Gastrointestinal Endoscopy, 85, 1005-1013.
https://doi.org/10.1016/j.gie.2016.10.033
|
[32]
|
Patai, Á., Solymosi, N. and Patai, Á.V. (2015) Effect of Rectal Indomethacin for Preventing Post-ERCP Pancreatitis Depends on Difficulties of Cannulation: Results from a Randomized Study with Sequential Biliary Intubation. Journal of Clinical Gastroenterology, 49, 429-437. https://doi.org/10.1097/MCG.0000000000000168
|
[33]
|
Patil, S., Pandey, V., Pandav, N., Ingle, M., Phadke, A. and Sawant, P. (2016) Role of Rectal Diclofenac Suppository for Prevention and Its Impact on Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients. Gastroenterology Research, 9, 47-52. https://doi.org/10.14740/gr672w
|
[34]
|
Masjedizadeh, A., Fathizadeh, P. and Aghamohamadi, N. (2017) Comparative Effectiveness of Aggressive Intravenous Fluid Resuscitation with Lactated Ringer’s Solution and Rectal Indomethacin Therapy in the Prevention of Pancreatitis after Endoscopic Retrograde Cholangiopancreatography: A Double Blind Randomised Controlled Clinical Trial. Przegla̜d Gastroenterologiczny, 12, 271-276. https://doi.org/10.5114/pg.2017.72102
|
[35]
|
Sadeghi, A., Abbasinazari, M., AsadzadehAghdaei, H., et al. (2019) Does Melatonin Addition to Indomethacin Decrease Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis? A Randomized Double-Blind Controlled Trial. European Journal of Gastroenterology & Hepatology, 31, 1350-1355.
https://doi.org/10.1097/MEG.0000000000001531
|
[36]
|
Sotoudehmanesh, R., Eloubeidi, M.A., Asgari, A.A., Farsinejad, M. and Khatibian, M. (2014) A Randomized Trial of Rectal Indomethacin and Sublingual Nitrates to Prevent Post-ERCP Pancreatitis. American Journal of Gastroenterology, 109, 903-909. https://doi.org/10.1038/ajg.2014.9
|
[37]
|
Murray, B., Carter, R., Imrie, C., Evans, S. and O’Suilleabhain, C. (2003) Diclofenac Reduces the Incidence of Acute Pancreatitis after Endoscopic Retrograde Cholangiopancreatography. Gastroenterology, 124, 1786-1791.
https://doi.org/10.1016/S0016-5085(03)00384-6
|
[38]
|
Oh, H.C., Kang, H., Park, T.Y., Choi, G.J. and Lehman, G.A. (2021) Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis with a Combination of Pharmacological Agents Based on Rectal Non-Steroidal Anti-Inflammatory Drugs: A Systematic Review and Network Meta-Analysis. Journal of Gastroenterology and Hepatology, 36, 1403-1413. https://doi.org/10.1111/jgh.15303
|
[39]
|
Staritz, M., Poralla, T., Ewe, K. and Meyer zum Buschenfelde, K.H. (1985) Effect of Glyceryl Trinitrate on the Sphincter of Oddi Motility and Baseline Pressure. Gut, 26, 194-197. https://doi.org/10.1136/gut.26.2.194
|
[40]
|
Tenner, S., Baillie, J., DeWitt, J. and Vege, S.S. (2013) American College of Gastroenterology Guideline: Management of Acute Pancreatitis [Published Correction Appears in American Journal of Gastroenterology. 2014 Feb; 109(2): 302]. American Journal of Gastroenterology, 108, 1400-1416. https://doi.org/10.1038/ajg.2013.458
|
[41]
|
Iqbal, U., Siddique, O., Khara, H.S., et al. (2020) Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prevention Using Topical Epinephrine: Systematic Review and Meta-Analysis. Endoscopy International Open, 8, E1061-E1067. https://doi.org/10.1055/a-1190-3777
|
[42]
|
Aziz, M., Ghanim, M., Sheikh, T., et al. (2020) Rectal Indomethacin with Topical Epinephrine versus Indomethacin Alone for Preventing Post-ERCP Pancreatitis—A Systematic Review and Meta-Analysis. Pancreatology, 20, 356-361.
https://doi.org/10.1016/j.pan.2020.02.003
|
[43]
|
Gromski, M.A. and Fogel, E.L. (2019) End of the Road for Epinephrine Spraying of the Papilla to Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis? Clinical Gastroenterology and Hepatology, 17, 1446-1447. https://doi.org/10.1016/j.cgh.2018.12.043
|
[44]
|
Rana, S.S. (2020) High-Dose NSAIDs and Pancreatitis after ERCP: More Is Not Always Better. The Lancet Gastroenterology and Hepatology, 5, 95-97. https://doi.org/10.1016/S2468-1253(19)30359-0
|
[45]
|
Hajalikhani, M., Emami, M.H., Khodadoostan, M., Shavakhi, A., Rezaei, M. and Soluki, R. (2018) Combination of Diclofenac and Aggressive Hydration for the Prevention of Post-ERCP Pancreatitis. Gastroenterology and Hepatology from Bed to Bench, 11, 319-324.
|